Faster global financial news!
Electra Therapeutics seeks a valuation of $977.6 million in its US IPO, aiming to raise $346.7 million.
The South San Francisco-based drug developer plans to list on Nasdaq under the ticker "ETRA," offering approximately 21.67 million shares at a price range of $14 to $16 per share. This listing comes amid a resurgence in biotech IPOs, with Electra Therapeutics intending to use the IPO proceeds to fund clinical trials for its lead experimental drug, ipsoprubart, and advance the development of its second candidate, ELA822.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
The 10-year U.S. Treasury yield is down approximately 8 basis points from its previous close, currently at 4.96%.
-
2
Google and Microsoft's Q3 capital expenditure falls short of estimates, raising concerns about AI build-out costs and delays
-
3
Report: Hedge Funds Exit Bitcoin ETF Arbitrage Trades, Sovereign Wealth Funds and Retail Investors Step In
-
4
New ECB staff estimates show bond yield rise cutting 2027-28 growth by a cumulative 100 BPS and inflation by 90 BPS vs Sept baseline.
-
5
Iranian President Pezeshkian stated that Iran is ready to expand cooperation with Turkey to serve common interests and enhance regional security.
-
6
Event prediction platform Kalshi completes $1 billion funding round, reaching a valuation of $40 billion, with non-sports revenue run rate exceeding $1 billion.
-
7
Israel continues its attacks on Gaza, with the Gaza Ministry of Health stating that dozens have died while awaiting permission to leave, renewing calls to open the Rafah crossing.
-
8
DBS Hong Kong to launch DBS Vantage Card, Hong Kong's first Visa Infinite Privilege Card
-
9
Unlimit founder backs Phase blockchain with $45M as mainnet launches
-
10
onXRP Team to Launch New Trading Method on XRP Ledger Next Week
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
